(Q48738439)

15 February 2018

title

Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses. (English)

1 reference

15 February 2018

author name string

Beranek L

1

1 reference

15 February 2018

Hajdu I

2

1 reference

15 February 2018

Gardi J

3

1 reference

15 February 2018

Taishi P

4

1 reference

15 February 2018

Obál F Jr

5

1 reference

15 February 2018

Krueger JM

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

15 February 2018

American Journal of Physiology

published in

1 reference

15 February 2018

volume

277

1 reference

15 February 2018

issue

5 Pt 2

1 reference

15 February 2018

page(s)

R1297-304

1 reference

15 February 2018

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Neuroendocrine regulation of growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Endogenous sleep-promoting substances and sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Reversal of desipramine-induced suppression of paradoxical sleep by a long-acting somatostatin analogue (octreotide) in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Central somatostatin: a re-examination of its effects on feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Effects of 12-h sleep deprivation and of 12-h cold exposure on sleep regulation and cortical temperature in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Somatostatin impairs sleep in elderly human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

The effect of SRIF on the EEG sleep of normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Preoptic/anterior hypothalamic warming increases EEG delta frequency activity within non-rapid eye movement sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Behavioural and electrocortical spectrum power effects of growth hormone releasing factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Antiserum to growth hormone decreases sleep in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Insulin-like growth factor-1 (IGF-1)-induced inhibition of growth hormone secretion is associated with sleep suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Somatostatin receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

On the fate of centrally administered somatostatin in the rat: massive hypersomatostatinemia resulting from leakage into the peripheral circulation has effects on growth hormone secretion and glucoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Sleep deprivation increases somatostatin and growth hormone-releasing hormone messenger RNA in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Physiology of growth hormone secretion during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

A new feature of angiotensin-converting enzyme in the brain: Hydrolysis of substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.1999.277.5.R1297

10.1152/AJPREGU.1999.277.5.R1297

21 January 2018

Identifiers

DOI

0 references

PubMed ID

10564200

1 reference

15 February 2018